期刊
JOURNAL OF MOLECULAR GRAPHICS & MODELLING
卷 64, 期 -, 页码 101-109出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jmgm.2016.01.006
关键词
Hypoxia-induced cancer; Carbonic anhydrase IX inhibitor; Drug design and discovery; Triazolo-pyrimidine urea; MD simulation
类别
资金
- University Grants Commission (UGC), New Delhi, India
- University of Delhi
- Department of Science and Technology (Government of India)
- Indian Council for Medical Research (ICMR)
- Department of Science and Technology, Government of India [SR/FST/LSI-541/2012]
Carbonic anhydrase IX (CAIX) is a promising target in cancer therapy especially in the case of hypoxia-induced tumors. The selective inhibition of CA isozymes is a challenging task in drug design and discovery process. Here, we performed fluorescence-binding studies and inhibition assay combined with molecular docking and molecular dynamics (MD) simulation analyses to determine the binding affinity of two synthesized triazolo-pyrimidine urea derived (TPUI and TPUII) compounds with CAIX and CAN. Fluorescence binding results are showing that molecule TPUI has an excellent binding-affinity for CAIX (k(D) = 0.048 mu M). The TPUII also exhibits an appreciable binding affinity (k(D) = 7.521 mu M) for CAIX. TPUI selectively inhibits CAIX as compared to TPUII in the 4-NPA assay. Docking studies show that TPUI is spatially well-fitted in the active site cavity of CAIX, and is involve in H-bond interactions with His94, His96, His119, Thr199 and Thr200. MD simulation studies revealed that TPUI efficiently binds to CAIX and essential active site residual interaction is consistent during the entire simulation of 40 ns. These studies suggest that TPUI appeared as novel class of CAIX inhibitor, and may be used as a lead molecule for the development of potent and selective CAIX inhibitor for the hypoxia-induced cancer therapy. (C) 2016 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据